Although the exact activator or mechanism of the NLRP3 inflammasome is not known, it can be determined that MLFE normalizes the levels of the NLRP3 inflammasome and suppresses skin inflammatory responses during the early stages of wound healing in obesity (67). Here, NLRP3 is linked to obesity disorder.